Bill
Gene Technology Amendment Bill 2015
passed, as at 2015-09-10. Health portfolio.
- Sponsor
- Not recorded
- Portfolio
- Health
Recorded stages
- introduced — 2015-06-18
- second reading — 2015-06-18
- second reading — 2015-08-19
- second reading — 2015-08-19
- third reading — 2015-08-19
- introduced — 2015-08-20
- second reading — 2015-08-20
- second reading — 2015-08-20
- second reading — 2015-08-20
- third reading — 2015-08-20
- passed — 2015-08-20
- royal assent — 2015-09-10
Divisions
No divisions recorded. Most questions are decided on the voices; this does not establish that a bill was unopposed.
Plain-language summary
Written by a model from the explanatory memorandum; not the record, as at 2015-06-18.
The bill would make minor and technical changes to the Gene Technology Act 2000 without altering its core intent or the national regulatory framework for gene technology.
It would implement five recommendations from a 2011 independent review, including ending quarterly ministerial reports and clarifying rules for inadvertent dealings licences.
The changes would also remove information on GM products authorised by other agencies from the Regulator's record and allow more flexible licence variation requirements.
- Quarterly reporting to the Minister would be discontinued.
- The types of dealings that can be covered by an inadvertent dealings licence would be clarified.
- Information about GM products approved by other agencies would be taken out of the Gene Technology Regulator's record.
- Licence holders would get more flexibility through changed variation requirements.
- The factors considered before dealings are classified as notifiable low risk dealings would be updated.
- Ambiguous wording in the Act would be clarified.
The Gene Technology Regulator, licence holders, and the Minister would be affected by the proposed changes.
Sources
em
billhome
frl act